Sai Life Sciences’ IPO saw an 84% subscription rate on its first day. Institutional investors showed strong interest. The IPO aims to raise Rs 3,042 crore. The company plans to use the funds for debt repayment. Analysts are cautious due to the IPO’s high valuation. The offer includes a large OFS component. The IPO closes on December 13.
Paul Black’s 3 thumb rules for identifying great wealth creators
Veteran portfolio manager Paul Black’s investment framework focuses on identifying businesses with competitive advantages that strengthen over time. His three key rules emphasise widening moats,